What Researchers Did
Researchers used a pressure chamber and tympanometry to study how a nasal spray called betahistine affected Eustachian tube function in people with ear problems.
What They Found
When chamber pressure increased to +3 kPa, one swallow reduced middle-ear pressure by an average of 1.36 kPa. The study identified four different patterns of Eustachian tube behavior, with three of these indicating a problem. Importantly, topical betahistine did not improve Eustachian tube opening.
What This Means for Canadian Patients
For Canadian patients experiencing Eustachian tube dysfunction, this study suggests that topical betahistine nasal spray is not an effective treatment. Patients should discuss other potential management strategies with their healthcare providers if they have ear pressure problems.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study focused on subjects who self-reported Eustachian tube abnormalities, which may limit how broadly these findings apply to all patients.